The present study demonstrates that oral administration of NES-428 significantly ameliorates hyperthyroidism induced by TSHR overexpression in a murine hyperthyroidism model, supporting the potential of NES-428 as a preventive agent for autoimmune thyroid disorders such as Graves’ disease. The gene discussed is TSHR; the disease is Graves disease.